SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Scott D Grosse, Shraddha S Chaugule, Joel W Hay, Estimates of utility weights in hemophilia: implications for cost-utility analysis of clotting factor prophylaxis, Expert Review of Pharmacoeconomics & Outcomes Research, 2015, 15, 2, 267

    CrossRef

  2. 2
    M. Ozelo, P. Chowdary, A. Regnault, A. K. Busk, Impact of severe haemophilia A on patients' health status: results from the guardian 1 clinical trial of turoctocog alfa (NovoEight®), Haemophilia, 2015, 21, 4
  3. 3
    M. Serban, D. Poenaru, J. Patrascu, E. Ursu, D. Savescu, H. Ionita, C. Jinca, L. Pop, S. Talpos-Niculescu, L. Ritli, S. Arghirescu, D. Mihailov, W. Schramm, Risks and challenges of orthopaedic invasive interventions in haemophilia in a low-resource country, Hämostaseologie, 2014, 34, Suppl. 1, S35

    CrossRef

  4. 4
    E.C. Rodriguez-Merchan, The knee in severe haemophilia with special emphasis on surgical/invasive procedures, Thrombosis Research, 2014, 134, 3, 545

    CrossRef